Navigation Links
Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
Date:1/25/2008

http://www.affymax.com.

This release contains forward-looking statements, including statements regarding the timing, design and results of the Companies' clinical trials and drug development program and the timing and likelihood of the commercialization of Hematide. The Companies' actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties, including risks relating to the continued safety and efficacy of Hematide in clinical development, the potential for once per month dosing, the timing of patient accrual in ongoing and planned clinical studies, regulatory requirements and approvals, research and development efforts, industry and competitive environment, intellectual property rights and disputes and other matters that are described in Affymax's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Companies undertake no obligation to update any forward-looking statement in this press release.


'/>"/>
SOURCE Takeda Pharmaceutical Company Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
2. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
3. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
4. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
5. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
10. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
11. Tainted Chinese Food Ingredients First Discovered in 2005
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Engineered Technologies (HDT), a leader in the development ... for the mechanical development of the Modular Prosthetic ... technology that will give patients improved, dexterous control ... sense of touch. ,, As part of ... Prosthetics 2009 (RP2009) project, the MPL overcomes the ...
(Date:12/16/2009)... -- Accuray Incorporated (Nasdaq: ARAY ), a global ... its president and chief executive officer, Euan S. Thomson, ... J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... ,, A live webcast of each presentation will ... the Company,s Web site at http://www.accuray.com . ...
(Date:12/16/2009)... 16 DATATRAK International, Inc. (OTCQX: ... on global eClinical solutions for the clinical ... its version 9.0 eClinical Software. This ... product and service delivery and introduces two ... offering: the DATATRAK Learning Center(TM) and the ...
Breaking Medicine Technology:HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 28R 29 25 MG and 50 MG 53550 1Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 28R 29 25 MG and 50 MG 53550 2Uroplasty Reports First Fiscal Quarter Results 53547 1Uroplasty Reports First Fiscal Quarter Results 53547 2Uroplasty Reports First Fiscal Quarter Results 53547 3Uroplasty Reports First Fiscal Quarter Results 53547 4Uroplasty Reports First Fiscal Quarter Results 53547 5Uroplasty Reports First Fiscal Quarter Results 53547 6Uroplasty Reports First Fiscal Quarter Results 53547 7Uroplasty Reports First Fiscal Quarter Results 53547 8Uroplasty Reports First Fiscal Quarter Results 53547 9Uroplasty Reports First Fiscal Quarter Results 53547 10Uroplasty Reports First Fiscal Quarter Results 53547 11Uroplasty Reports First Fiscal Quarter Results 53547 12Uroplasty Reports First Fiscal Quarter Results 53547 13Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 1Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 2Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 3Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 4Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 5Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 6Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 7Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 8Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 9Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 10
(Date:12/17/2009)... StaffKnex, developers of web-based nurse scheduling and employee communication ... to deliver its software solution to all Lifespace Communities ... ... Cleveland, OH (PRWEB) December 17, 2009 -- StaffKnex ( ... communication software, recently announced it was selected by Lifespace ...
(Date:12/17/2009)... Baptist with on-going Healthcare Cost/Risk Analysis reports, activity measures and ... as it translates toward reduced claim costs and positive return ... , ... Jacksonville, FL (PRWEB) December ... management company specializing in clinical/claims based cost risk analysis along ...
(Date:12/16/2009)... Dec. 17 Health care sector revenue ... trillion, up from $1.66 trillion in 2007, according ... This sector is classified under the North American ... http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) ,, These figures come from ... and Social Assistance , a series of tables ...
(Date:12/16/2009)... year in the United States, 160,000 cases of colorectal ... disease, making it the second leading cause of death ... researchers and clinicians fervently look for causes and cures ... producing more and more promising results Dr. Sanford ... Case Western Reserve University School of Medicine and oncologist ...
(Date:12/16/2009)... For wounded U.S. servicemen and women recovering at ... holidays can be a particularly difficult time. Wounded ... than ever on the healing power of connecting with ... got easier for Walter Reed patients as Verizon Wireless ... hundreds of minutes of holiday talk time for 2,500 ...
Breaking Medicine News(10 mins):Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 2Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 3Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 3Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2
... Palomar Medical Technologies, Inc. (Nasdaq: PMTI ... for cosmetic treatments, announced today that Palomar won two ... on May 6 and 13, 2009. The opposition ... 0 806 913, respectively, which correspond to U.S. Patent ...
... Announces Partnership to Provide New Yorkers with Free HIV/AIDS TestingNEW ... today announced that The Duane Reade Charitable Foundation has doubled ... a Premier-level sponsor of AIDS Walk New York (AWNY). ... fifty other AIDS service organizations in the New York tri-state ...
... Research on Antioxidant-Enhanced SuncareKENILWORTH, N.J., May 14 ... SGP ), introduces COPPERTONE (R) , NutraShield ... new line of sunscreens enriched with antioxidants to ... free radicals created by UV exposure. (Photo: ...
... All New 4th Edition NEW YORK, May 14 ... Spinal Network: The Total Wheelchair Resource Book , ... is now available.This 400-page guide provides information on health, ... and sexuality, fertility and parenting, adaptive technology, spinal cord ...
... legislative action in the best interests of the ... bank accounts?COLLEYVILLE, Texas, May 14 Our leading ... marketed e-cigarettes. This parade is lead by the ... health conscious senator, who has taken well over ...
... Healthcare has launched the free online board, MedicalMissions.org ( http://www.medicalmissions.org ... around the world. The new website is designed for charitable ... volunteer interests and needs. , ... ...
Other Medicine News:Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 2Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 3Health News:Palomar Wins Two European Hair Removal Patent Opposition Hearings 4Health News:Duane Reade Announces Premier-Level Sponsorship of AIDS Walk New York 2Health News:Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair 2Health News:Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair 3Health News:Spinal Network: The Total Wheelchair Resource Book 2Health News:Proposed E-Cigarette Ban Pushed in the Name of America's Health Actually a Backdoor Boost to Pharmaceutical Companies 2Health News:Free Medical Mission 'Job Board' Launched 2Health News:Free Medical Mission 'Job Board' Launched 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: